Theravance Inc

Number of records: 13
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
13-Jul-22 9:27 PM
View: 
Entasis Therapeutics Holdin... (ETTX) 11-Jul-22Purchase 7,598,810$2.20$16,717,400.0012%
62.02M to 69.61M
13-Jul-22 9:27 PM
View: 
Entasis Therapeutics Holdin... (ETTX) 08-Jul-22Private Purchase 11,671,700$2.20$25,677,700.0023%
50.34M to 62.02M
01-Apr-22 4:52 PM
View: 
Targeted Genetics Corp. (ARMP) 31-Mar-22Market Purchase 5,385,210$5.00$26,926,000.0027%
19.69M to 25.08M
3%
11-Feb-22 6:56 PM
View: 
Targeted Genetics Corp. (ARMP) 09-Feb-22Market Purchase 3,614,790$5.00$18,074,000.0022%
16.08M to 19.69M
3%
01-Nov-21 2:20 PM
View: 
Targeted Genetics Corp. (ARMP) 29-Oct-21Market Purchase 1,212,120$3.30$4,000,000.008%
14.86M to 16.08M
11-Jun-21 5:39 PM
View: 
Entasis Therapeutics Holdin... (ETTX) 11-Jun-21Private Purchase 6,268,980$2.00$12,538,000.0028%
22.4M to 28.67M
20-May-21 2:39 PM
View: 
Entasis Therapeutics Holdin... (ETTX) 03-May-21Private Purchase 3,731,020$2.00$7,462,050.0020%
18.67M to 22.4M
17-Mar-21 5:16 PM
View: 
Targeted Genetics Corp. (ARMP) 17-Mar-21Private Purchase 4,285,940$3.25$13,929,300.0041%
10.58M to 14.86M
28-Jan-21 1:43 PM
View: 
Targeted Genetics Corp. (ARMP) 26-Jan-21Private Purchase 1,867,910$3.25$6,070,710.0021%
8.71M to 10.58M
01-Sep-20 5:31 PM
View: 
Entasis Therapeutics Holdin... (ETTX) 01-Sep-20Private Purchase 4,672,900$2.67$12,500,000.0033%
14.0M to 18.67M
12-Jun-20 5:34 PM
View: 
Entasis Therapeutics Holdin... (ETTX) 11-Jun-20Private Purchase 12,677,500$2.50$31,693,700.00959%
1.32M to 14.0M
31-Mar-20 4:54 PM
View: 
Targeted Genetics Corp. (ARMP) 27-Mar-20Private Purchase 7,717,660$2.87$22,149,700.00777%
993.14K to 8.71M
(100%)
19-May-14 7:06 PM
View: 
Theravance Biopharma, Inc. (TBPH) 15-May-14Disposition (other) 33,100,000----(100%)
33.1M to 0